Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)
China · Delayed Price · Currency is CNY 54.38
+1.93 (3.68%)
Jul 16, 2025, 3:00 PM CST
SHA:688399 Revenue
Jiangsu Bioperfectus Technologies had revenue of 91.61M CNY in the quarter ending March 31, 2025, with 0.54% growth. This brings the company's revenue in the last twelve months to 350.10M, down -12.53% year-over-year. In the year 2024, Jiangsu Bioperfectus Technologies had annual revenue of 349.61M, down -13.29%.
Revenue (ttm)
350.10M
Revenue Growth
-12.53%
P/S Ratio
13.03
Revenue / Employee
591.38K
Employees
592
Market Cap
4.56B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |